Enterprise Value
25.75M
Cash
73.93M
Avg Qtr Burn
-22.07M
Short % of Float
1.90%
Insider Ownership
2.15%
Institutional Own.
74.24%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
SYSA1801 (EO-3021) Details Solid tumor/s | Phase 1 Initiation |